Based in France, Aterovax is a startup.
Aterovax is an in vitro diagnostics company developing blood-based tests for the screening and prevention of cardiovascular diseases. Founded in June 2006, its R&D focuses on cardiovascular biomarkers including sPLA2 and it maintains an international clinical and scientific advisory board.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.